Find policies, billing codes, payers, states, and providers
Loading...
Find policies, billing codes, payers, states, and providers
CPT 86805: Lymphocyte Crossmatch with Recipient Serum
CPT-86806-SEROLOGIC-CROSSMATCH-DONOR-LYMPHOCYTE-RECIPIENT-SERUMCPT 86806: Lymphocyte Crossmatch, Donor Lymphocytes with Recipient Serum
CPT-86807-HLA-ANTIBODY-SCREENING-TRANSPLANT-COMPATIBILITYCPT 86807: HLA Antibody Percent Reactive Screening
CPT-86808-HLA-PERCENT-REACTIVE-ANTIBODY-SCREENINGCPT 86808: HLA Percent Reactive Antibody Screen
CPT-86812-HLA-CLASS-I-SINGLE-ANTIGEN-SEROLOGIC-TESTCPT 86812: HLA Class I Antigen Serologic Typing
CPT-86813-HLA-CLASS-I-SEROLOGIC-TYPINGCPT 86813: HLA Class I Serologic Typing (A, B, C)
CPT-86816-HLA-CLASS-II-SEROLOGIC-SINGLE-ANTIGEN-TYPING-DR-DQCPT 86816: HLA Class II Single Antigen Serology
CPT-86817-HLA-CLASS-II-DR-DQ-SEROLOGIC-IDENTIFICATIONCPT 86817: HLA Class II DR/DQ Serologic Typing
CPT-86821-HLA-LYMPHOCYTE-CROSSMATCH-COMPATIBILITY-TESTCPT 86821: Lymphocyte Crossmatch for HLA Incompatibility
CPT-86825-HLA-CROSSMATCH-FLOW-CYTOMETRYCPT 86825: HLA Crossmatch by Non-Cytotoxic Method
Showing 1–10 of 20
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.